Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC‐3 cells

Fibroblast growth factors (FGFs) and their receptors (FGFRs) expedite stromal–epithelial communication in development and homeostasis of the human prostate. Loss of resident epithelial cell FGFR2IIIb that responds to stromal FGF7 and FGF10 accompanies malignant progression of both model animal and human prostate tumors.

[1]  P. Fisher,et al.  Bcl-2 and Bcl-xL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24 , 2003, Oncogene.

[2]  C. Korch,et al.  Molecular characterization of human prostate carcinoma cell lines , 2003, The Prostate.

[3]  S. Hayward,et al.  Role of the stromal microenvironment in carcinogenesis of the prostate , 2003, International journal of cancer.

[4]  P. Scardino,et al.  The prevention of prostate cancer--the dilemma continues. , 2003, The New England journal of medicine.

[5]  O. Cussenot,et al.  Down‐regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate , 2002, The Prostate.

[6]  Xiaochong Wu,et al.  Directional specificity of prostate stromal to epithelial cell communication via FGF7/FGFR2 is set by cell- and FGFR2 isoform-specific heparan sulfate , 2001, In Vitro Cellular & Developmental Biology - Animal.

[7]  M. Kan,et al.  Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  N. Ohtake,et al.  Trends and characteristics in prostate cancer mortality in Japan , 2000, International journal of urology : official journal of the Japanese Urological Association.

[9]  D. Chopin,et al.  Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer , 1999, Oncogene.

[10]  M. Ittmann,et al.  Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  H. Yamanaka,et al.  Androgen-stimulated human prostate epithelial growth mediated by stromal-derived fibroblast growth factor-10. , 1999, Endocrine journal.

[12]  A. Matsubara,et al.  Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. , 1998, Cancer research.

[13]  Russ P Carstens,et al.  Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer , 1997, Oncogene.

[14]  A. Matsubara,et al.  Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. , 1997, Cancer research.

[15]  B. Foster,et al.  Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. , 1996, The International journal of developmental biology.

[16]  W. Mckeehan,et al.  Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy , 1993, Molecular and cellular biology.

[17]  W. Mckeehan,et al.  Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. , 1992, Molecular endocrinology.

[18]  S. Werner,et al.  Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities , 1992, Molecular and cellular biology.

[19]  T. Thompson,et al.  Epithelial-mesenchymal interactions in prostatic development. II. Biochemical observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder , 1983, The Journal of cell biology.

[20]  G. Cunha.  Epithelio‐mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation , 1972, The Anatomical record.

[21]  M. Sande,et al.  Lactoferrin in human prostate tissue , 2004, Urological Research.

[22]  M. Ittmann,et al.  Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia , 2004, The Prostate.

[23]  G. Tuccari,et al.  Lactoferrin in benign hypertrophy and carcinomas of the prostatic gland , 2004, Virchows Archiv A.

[24]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.